Signaling through both A2AR and A2BR involves activation of the PI3K/Akt signaling pathway, subsequently promoting epithelial–mesenchymal transition (EMT) in tumors, tumor cell proliferation, and metastasis [95]. The gene discussed is ADORA2A; the disease is neoplasm.